Cargando…

2491. The Association of Parkinson’s Disease with Hepatitis C Virus Infection and Its Treatment

BACKGROUND: There are contradicting reports regarding the relationship between hepatitis C virus (HCV) infection and its treatment with idiopathic Parkinson’s Disease (PD). We sought to determine the association of HCV infection and its treatment with idiopathic PD. METHODS: We used the Electronical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aslam, Samia, Yan, Peng, Butt, Adeel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677238/ http://dx.doi.org/10.1093/ofid/ofad500.2109

Ejemplares similares

294. Hepatitis C Virologic Response in Hepatitis B and C Coinfected Persons Treated with Directly Acting Antiviral Agents: Results from ERCHIVES
por: Butt, Adeel A, et al.
Publicado: (2019)

2219. Treatment Uptake for Hepatitis C Virus Infection in the Veterans Affairs Healthcare System in the Era of Directly Acting Antiviral Agents: An ERCHIVES Study
por: Butt, Adeel Ajwad, et al.
Publicado: (2018)

2491. Post-Exposure Prophylaxis With Ribavirin Plus Lopinavir/Ritonavir for Middle East Respiratory Syndrome in Healthcare Workers
por: Park, So Yeon, et al.
Publicado: (2018)

2896. Reduction in Liver-related Mortality Among HCV Infected Persons Is Driven by Attainment of SVR Independent of the Regimen Used: Results from the ERCHIVES Cohort
por: Butt, Adeel A, et al.
Publicado: (2019)

285. Fibrosis Progression and Clinical Outcomes in HCV/HBV Coinfected Persons in the ERCHIVES Cohort
por: Butt, Adeel A, et al.
Publicado: (2019)

514. Nirmatrelvir/ritonavir or Molnupiravir for Treatment of Non-hospitalized Patients with COVID-19 at Risk of Disease Progression
por: Butt, Adeel A, et al.
Publicado: (2023)

Fibrosis Progression and Incidence of Cirrhosis and Hepatic Decompensation in Persons Treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir: Results from ERCHIVES
por: Simon, Tracey, et al.
Publicado: (2017)

2491: Parental concerns about child participation in s reflect a need to move beyond traditional notions of trust and race
por: Erves, Jennifer, et al.
Publicado: (2018)

Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
por: Thomas, Konstantinos, et al.
Publicado: (2018)

PB2491: LANGERHANS CELL HISTIOCYTOSIS (LCH) IN THE MAXILLOFACIAL AREA IN ADULT. COMPLETE REMISSION WITH CLADRIBINE. CASE REPORT AND REVIEW.
por: De Miguel Llorente, Dunia, et al.
Publicado: (2023)

The Incidence of Hepatocellular Carcinoma Is not Increased in Individuals with Chronic Hepatitis C After Treatment with Interferon-free Regimens: an ERCHIVES Study
por: Li, Darrick K, et al.
Publicado: (2017)

Mixed Genotype Infections with Hepatitis C Virus, Pakistan
por: Butt, Sadia, et al.
Publicado: (2011)

Is DAA Treatment Associated with HBV Reactivation? Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)

2209. Discordance Between FibroSure and FibroScan Results in Hepatitis C and Human Immunodeficiency Virus Co-infected Patients Prior to Treatment for Hepatitis C Virus Infection
por: Tiyouh, Melissa, et al.
Publicado: (2018)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

930. HCV Treatment Is Associated With a Reduced Risk of Cardiovascular Disease Events: Results From ERCHIVES
por: Butt, Adeel Ajwad, et al.
Publicado: (2018)

Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use
por: Butt, Adeel A., et al.
Publicado: (2021)

2491. Virologic Response of Switching Tenofovir Disoproxil Fumarate (TDF)-Based Regimen to Abacavir (ABC)-Based Regimen vs. Lopinavir/Ritonavir(LPV/r) Plus Lamivudine(3TC) in HIV-Infected Patients with TDF-Induced Nephrotoxicity at 24 Weeks: A Prospective, Open-Label, Randomized, Controlled Trial
por: Songumpai, Nopporn, et al.
Publicado: (2019)

2221. Active Substance Use Should Not Be a Contraindication for Hepatitis C Treatment in Hepatitis C and Human Immunodeficiency Virus Co-infected Patients
por: Zeineddine, Nabil, et al.
Publicado: (2018)

304. Hepatocellular Carcinoma Occurs Frequently and Early After Treatment in HCV Genotype 3 Infected Persons Treated with DAA Regimens
por: Un Nabi Tayyab, Ghias, et al.
Publicado: (2019)

Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection
por: Erqou, Sebhat, et al.
Publicado: (2014)

2228. Late Viral Relapse After Direct-Acting Antiviral Treatment in Hepatitis C Virus-Infected Cancer Patients
por: Angelidakis, Georgios, et al.
Publicado: (2018)

HCV Treatment Initiation in Patients with Chronic Kidney Disease: Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)

A12 Predictors of treatment failure among Irish individuals infected with hepatitis C virus
por: Dean, J., et al.
Publicado: (2017)

Computational analysis of control of hepatitis B virus disease through vaccination and treatment strategies
por: Butt, Azhar Iqbal Kashif, et al.
Publicado: (2023)

The use of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients with Hepatocellular Carcinoma
por: Economides, Minas, et al.
Publicado: (2017)

1757. Hepatitis C-Infected Donors and Hepatitis C-Infected Recipients: Analysis of Renal Transplant Outcomes
por: Crossman, Hayley, et al.
Publicado: (2019)

2225. Acute Hepatitis C Virus Infections in HIV-Infected Persons in the Era of Direct-Acting Antiviral Therapy
por: Cartwright, Emily J, et al.
Publicado: (2018)

Implementation of a Comprehensive Hepatitis C Virus (HCV) Treatment Program in Metro-Detroit
por: Awali, Reda, et al.
Publicado: (2017)

1981. Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection on Opioid Substitution Therapy: Latest Results from the German Hepatitis C-Registry
por: Reimer, Jens, et al.
Publicado: (2018)

362. Hepatitis C Virus (HCV) Co-Infection in Women Living with Human Immunodeficiency Virus (HIV) in Northwest Louisiana
por: Mohammed, Ethar, et al.
Publicado: (2019)

2227. Short-Duration of Direct-Acting Antivirals in Hepatitis C Virus-Infected Cancer Patients
por: Hosry, Jeff, et al.
Publicado: (2018)

2217. Demographic Trends and Health Care Utilization Among Children With Hepatitis C Virus Infection
por: Lee, Brian R, et al.
Publicado: (2018)

293. Hepatitis C is now a Millennial Disease in Response to the Opioid Crisis: A Demographic Shift in Hepatitis C Infection
por: Rose, Michelle, et al.
Publicado: (2019)

2197. Hepatitis B Reactivation in Patients with Malignancies Undergoing Treatment for Hepatitis C Infection with Direct-Acting Antivirals
por: Pritchard, Haley, et al.
Publicado: (2018)

Serology based disease status of Pakistani population infected with Hepatitis B virus
por: Alam, Muhammad Masroor, et al.
Publicado: (2007)

The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease
por: De Comarmond, Charles, et al.
Publicado: (2017)

1516. High Incidence of Newly Infected Syphilis, Hepatitis B and C Virus among People Living with HIV Who Have Reached U=U
por: Ge, lingyun, et al.
Publicado: (2023)

Hepatitis C Virus Treatment Response to Ledipasvir/Sofosbuvir Among Patients Co-Infected with HIV and HCV: Real-world Data in a Black Population
por: Banga, Jaspreet, et al.
Publicado: (2017)

1073. The Time is Now for Rapid Initiation of Hepatitis C Virus (HCV) Treatment
por: Radford, Colton P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s5jnju868jo9d4rt469qd3kmvc